GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Financial Ratios History
[Consolidated]
Mar2024 | |
---|---|
Operational & Financial Ratios | |
Earnings Per Share (Rs) | 8.59 |
CEPS(Rs) | 10.29 |
DPS(Rs) | 0.10 |
Book NAV/Share(Rs) | 53.11 |
Tax Rate(%) | 25.53 |
Margin Ratios | |
Core EBITDA Margin(%) | 15.52 |
EBIT Margin(%) | 13.94 |
Pre Tax Margin(%) | 12.30 |
PAT Margin (%) | 9.16 |
Cash Profit Margin (%) | 10.97 |
Performance Ratios | |
ROA(%) | 7.88 |
ROE(%) | 16.17 |
ROCE(%) | 15.42 |
Asset Turnover(x) | 0.86 |
Sales/Fixed Asset(x) | 3.82 |
Working Capital/Sales(x) | 4.12 |
Efficiency Ratios | |
Fixed Capital/Sales(x) | 0.26 |
Receivable days | 128.09 |
Inventory Days | 77.83 |
Payable days | 178.99 |
Valuation Parameters | |
PER(x) | 32.96 |
PCE(x) | 27.53 |
Price/Book(x) | 5.33 |
Yield(%) | 0.04 |
EV/Net Sales(x) | 3.90 |
EV/Core EBITDA(x) | 21.23 |
EV/EBIT(x) | 23.99 |
EV/CE(x) | 3.70 |
M Cap / Sales | 3.52 |
Growth Ratio | |
Net Sales Growth(%) | - |
Core EBITDA Growth(%) | - |
EBIT Growth(%) | - |
PAT Growth(%) | - |
EPS Growth(%) | - |
Financial Stability Ratios | |
Total Debt/Equity(x) | 0.60 |
Current Ratio(x) | 1.61 |
Quick Ratio(x) | 1.08 |
Interest Cover(x) | 8.53 |
Total Debt/Mcap(x) | 0.11 |
Compare Financial Ratios of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,560.7 Cr | -2.2% | -5.1% | -7.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -2.2% |
-5.1% |
-7.2% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses